Market revenue in 2019 | USD 426.7 million |
Market revenue in 2026 | USD 667.8 million |
Growth rate | 6.6% (CAGR from 2019 to 2026) |
Largest segment | Directional atherectomy |
Fastest growing segment | Laser atherectomy |
Historical data | 2015 - 2018 |
Base year | 2019 |
Forecast period | 2020 - 2026 |
Quantitative units | Revenue in USD million |
Market segmentation | Directional atherectomy, Rotational atherectomy, Orbital atherectomy, Laser atherectomy |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Koninklijke Philips NV, BD, Abbott Laboratories, Avinger Inc, Cardiovascular Systems, Cardinal Health Inc, Terumo Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to atherectomy devices market will help companies and investors design strategic landscapes.
Directional atherectomy was the largest segment with a revenue share of 36.98% in 2019. Horizon Databook has segmented the U.S. atherectomy devices market based on directional atherectomy, rotational atherectomy, orbital atherectomy, laser atherectomy covering the revenue growth of each sub-segment from 2015 to 2026.
High prevalence of Peripheral Artery Diseases (PAD) in the region is one of the key reasons of high demand of atherectomy in the U.S. Almost 8.5 million people suffer from PAD, with an annual economic burden of nearly USD 160 million.
Severe cases of PAD can result in ischemic amputation, which is a severe problem. Almost 54% of amputations are due to PAD and diabetes. This number is higher than trauma and cancer cases. The racial trend suggests that people of Hispanic origin are more susceptible to these diseases than non-Hispanic whites.
This portrays the demand of atherectomy procedures in the country. Conventional treatment of PAD, surgical bypass, was effective, but is invasive in nature and causes long hospital stays and other complications, such as infections. This resulted in shift toward endovascular procedures.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. atherectomy devices market, including forecasts for subscribers. This country databook contains high-level insights into U.S. atherectomy devices market from 2015 to 2026, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account